Coppell Advisory Solutions Corp’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-423
Closed -$50.5K 752
2022
Q4
$50.5K Buy
+423
New +$50.5K 0.02% 296